Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Win

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
British Journal of Cancer|June 12, 2014
Characterisation of familial colorectal cancer Type X, Lynch syndrome, and non-familial colorectal cancerS Shiovitz, W K Copeland, M N Passarelli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 7, 2013
Family history of colorectal cancer in BRAF p.V600E-mutated colorectal cancer casesDaniel D Buchanan, Aung K Win, Michael D Walsh, et al.
The Journal of Molecular Diagnostics : JMD|December 31, 2020
Germline and Tumor Sequencing as a Diagnostic Tool To Resolve Suspected Lynch SyndromeBernard J Pope, Mark Clendenning, Christophe Rosty, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2023
Using DEPendency of Association on the Number of Top Hits (DEPTH) as a Complementary Tool to Identify Novel Colorectal Cancer Susceptibility LociJohn Lai, Chi Kuen Wong, Daniel F Schmidt, et al.
JNCI Cancer Spectrum|April 30, 2021
Assessment of a Polygenic Risk Score for Colorectal Cancer to Predict Risk of Lynch Syndrome Colorectal CancerMark A Jenkins, Daniel D Buchanan, John Lai, et al.
EMBO Molecular Medicine|December 3, 2014
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody responseZhisheng Her, Terk-Shin Teng, Jeslin J L Tan, et al.
Pathology|December 27, 2011
Using tumour pathology to identify people at high genetic risk of breast and colorectal cancersJ L Hopper, M A Jenkins, J G Dowty, et al.
Genes, Chromosomes & Cancer|March 29, 2014
Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registryDominique Scherer, Lisel M Koepl, Elizabeth M Poole, et al.
The American Journal of Surgical Pathology|April 19, 2012
Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinicsChristophe Rosty, Daniel D Buchanan, Michael D Walsh, et al.
Ebiomedicine|March 30, 2025
Intratumoural pks<sup>+</sup>Escherichia coli is associated with risk of metachronous colorectal cancer and adenoma development in people with Lynch syndromeYen Lin Chu, Peter Georgeson, Mark Clendenning, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|June 12, 2014
Characterisation of familial colorectal cancer Type X, Lynch syndrome, and non-familial colorectal cancerS Shiovitz, W K Copeland, M N Passarelli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 7, 2013
Family history of colorectal cancer in BRAF p.V600E-mutated colorectal cancer casesDaniel D Buchanan, Aung K Win, Michael D Walsh, et al.
The Journal of Molecular Diagnostics : JMD|December 31, 2020
Germline and Tumor Sequencing as a Diagnostic Tool To Resolve Suspected Lynch SyndromeBernard J Pope, Mark Clendenning, Christophe Rosty, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2023
Using DEPendency of Association on the Number of Top Hits (DEPTH) as a Complementary Tool to Identify Novel Colorectal Cancer Susceptibility LociJohn Lai, Chi Kuen Wong, Daniel F Schmidt, et al.
JNCI Cancer Spectrum|April 30, 2021
Assessment of a Polygenic Risk Score for Colorectal Cancer to Predict Risk of Lynch Syndrome Colorectal CancerMark A Jenkins, Daniel D Buchanan, John Lai, et al.
EMBO Molecular Medicine|December 3, 2014
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody responseZhisheng Her, Terk-Shin Teng, Jeslin J L Tan, et al.
Pathology|December 27, 2011
Using tumour pathology to identify people at high genetic risk of breast and colorectal cancersJ L Hopper, M A Jenkins, J G Dowty, et al.
Genes, Chromosomes & Cancer|March 29, 2014
Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registryDominique Scherer, Lisel M Koepl, Elizabeth M Poole, et al.
The American Journal of Surgical Pathology|April 19, 2012
Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinicsChristophe Rosty, Daniel D Buchanan, Michael D Walsh, et al.
Ebiomedicine|March 30, 2025
Intratumoural pks<sup>+</sup>Escherichia coli is associated with risk of metachronous colorectal cancer and adenoma development in people with Lynch syndromeYen Lin Chu, Peter Georgeson, Mark Clendenning, et al.
Pageof 9